The emerging treatment of the medication represents a major development in the handling of type 2 diabetes. Unlike existing therapies, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide533809.blogdosaga.com/42027133/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment